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Plasmodium gametocytes (GCT) have recently been pro-
posed as a crucial target for the development of new anti-
malarials in order to achieve malaria elimination and
eventually eradication. At present, however, a widely
accepted and routinely used screening method for potential
gametocytocidal drugs does not exist. The aim of our work
was to adapt the parasite lactate dehydrogenase (pLDH),
already standardised for drug screening on asexual stages,
to measure gametocyte drug sensitivity. In clinics the
GCT- pLDH, which is present during all the five stages of
gametocyte development, can be measured with good sen-
sitivity through OptiMAL, an immunochromatographic
diagnostic test. The pLDH assay is fast, simple, not expen-
sive and does not require complex equipment or special
waste disposal. It can be applied to field isolates since
transgenesis is not needed.
Gametocytogenesis of two different strains of P. falci-
parum, 3D7 and NF54, was induced in vitro using a stan-
dardized protocol, asexual parasites were removed by
N-acetylglucosamine treatment, and GCT were seeded in
96well plates. A linear correlation between the percentage
of gametocytemia, microscopically counted by Giemsa
staining, and the optical density, measured spectroscopi-
cally by pLDH assay, was demonstrated. A good signal to
noise ratio was obtained with the pLDH assay, and the
Z’factor was calculated as indicator of the robustness of
the method. Our data also indicate that GCT have a
pLDH activity higher than asexual parasites.
GCT were treated for 48-72h with primaquine, the gold
standard against mature gametocytes in vivo, which was
used to validate most of the GCT screening methods in
literature; dihydroartemisinin, active on young GCT; and
methylene blue, an old antimalarial recently characterised
also for its anti-GCT activity. Finally, epoxomicin was
tested since its strong gametocytocidal effect has been
recently reported. Dose-response curves were obtained
with all the four drugs. However, some discrepancies
were observed between the Giemsa staining and the
pLDH detection at high concentrations of the drugs, sug-
gesting that morphological abnormalities, detected
microscopically, precede the decay of pLDH activity in
drug-treated GCT. In order to better understand these
observations, we prolonged the treatment for further
72h. This extra-incubation period allowed us to calculate,
from the pLDH assay, the IC50 (as the 50% inhibition
compared to control untreated GCT) of the tested com-
pounds, which were comparable to those obtained by
Giemsa staining.
These results demonstrate the feasibility of pLDH assay
to measure GCT content in culture. Although more speci-
fic probes for GCT viability need to be standardized for
measuring stage-specific drug activity, pLDH can be used
as the first, fast and cheap screening method to find
potential gametocitocydal drugs.
Author details
1Dipartimento di Scienze Farmacologiche e Biomolecolari, Università di
Milano, Milan, 20134, Italy. 2Dipartimento di Scienze Biomediche, Chirurgiche
eOdontoiatriche, Università di Milano, Milan, 20133, Italy. 3Dipartimento di
Malattie lnfettive, Parassitarie, Immunomediate, Istituto Superiore di Sanità,
Roma, 00161, Italy. 4TroplQ Health Sciences, Nijmegen, 6525 GA, The
Netherlands. 5AVIS Comunale di Milano, Milan, 20133, Italy. 6Department of
Medical Microbiology, Radboud University Nijmegen Medical Center,
Nijmegen, 6525 GA, The Netherlands.
Published: 15 October 2012
doi:10.1186/1475-2875-11-S1-O34
Cite this article as: D’Alessandro et al.: A new P. falciparum gametocyte
drug screening assay based on pLDH detection. Malaria Journal 2012
11(Suppl 1):O34.
1Dipartimento di Scienze Farmacologiche e Biomolecolari, Università di
Milano, Milan, 20134, Italy
Full list of author information is available at the end of the article
D’Alessandro et al. Malaria Journal 2012, 11(Suppl 1):O34
http://www.malariajournal.com/content/11/S1/O34
© 2012 D’Alessandro et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
